Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025
50 $
Format : 9 videos + 1 pdf
File size: 5.12 GB
Date & Location Saturday, January 11, 2025, 7:30 AM – 5:00 PM, Johns Hopkins University School of Medicine, Turner Bldg., Baltimore, MD
Target Audience Specialties – Ophthalmology
Overview
Over the past several years, there is a growing body of medical evidence demonstrating a clear biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age related macular degeneration, diabetic retinopathy, and related diseases. Furthermore, there are new imaging and therapeutic approaches to vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina. These areas of investigation are relatively new, and most ophthalmologists are not aware of the myriad of new clinical trials relevant to these diseases. Thus, these subjects are areas of great interest both to ophthalmologists who treat these diseases and to those who refer these cases for further management. Presentations were chosen to emphasize new information and consensus on the use of these biologic agents to treat the neovascular and non-neovascular forms of age-related macular degeneration, vitreomacular interface abnormalities, diabetic retinopathy, intraocular tumors, and posterior uveitis. In addition, cases were chosen highlighting new information being reported by randomized clinical trials in these disease areas.
Objectives
- Explain the biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age-related macular degeneration, diabetic retinopathy, and related diseases.
- Discuss new imaging and therapeutic approaches to diabetic retinopathy, vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina.
- Review the current and emerging therapeutic approaches for surgical retinal diseases.
- Evaluate recent clinical studies evaluating treatments for retinal degenerations.
The Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025 is tailored for:
- Ophthalmologists: Specialists interested in the latest advancements in retinal diseases and treatments.
- Optometrists: Professionals seeking to deepen their knowledge of macular and retinal care.
- Ophthalmic Allied Health Professionals: Individuals involved in supporting retinal diagnostics and therapies.
The event focuses on cutting-edge research, imaging techniques, and therapeutic approaches for retinal diseases.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
Choroidal Neovascularization.mp4
Contemporary Retinal Imaging.mp4
Diabetic Macular Edema.mp4
Geographic Atrophy And Inhererited Retinal Diseases.mp4
Keynotes.mp4
MACULA-2025-Program-Jan-7-2025-1430.pdf
Ocular Tumors.mp4
Proliferative Diabetic Retinopathy.mp4
Retinal Vascular Diseases Other than Diabetic Retinopathy.mp4
Special Topics in Retina 2025.mp4
* Detail:
Saturday, January 11, 2025
Welcome; Conference Goals; Introduction of Keynote Talk
8:00AM – 8:05AM
Neil Bressler, MD
8:00AM – 8:05AM
Neil Bressler, MD
Welcome; Conference Goals; Introduction of Keynote Talk
8:00AM – 8:05AM
J. Fernando Arevalo, MD, PhD
8:00AM – 8:05AM
J. Fernando Arevalo, MD, PhD
Keynote Talk: Global Influence of NIH Funded Retina Networks
8:05AM – 8:20AM
Daniel F Martin, MD
8:05AM – 8:20AM
Daniel F Martin, MD
Contemporary Retinal Imaging – MODERATOR
8:20AM – 9:10AM
Amir H Kashani, MD, PhD
8:20AM – 9:10AM
Amir H Kashani, MD, PhD
Contemporary Retinal Imaging – MODERATOR
8:20AM – 9:10AM
Christina Y. Weng, MD, MBA
8:20AM – 9:10AM
Christina Y. Weng, MD, MBA
Contemporary Retinal Imaging – MODERATOR
8:20AM – 9:10AM
John B Miller, MD
8:20AM – 9:10AM
John B Miller, MD
Home Monitoring for Age-related Macular Degeneration
8:20AM – 8:30AM
Christina Y. Weng, MD, MBA
8:20AM – 8:30AM
Christina Y. Weng, MD, MBA
Managing Retina with OCT Angiography
8:30AM – 8:40AM
Amir H Kashani, MD, PhD
8:30AM – 8:40AM
Amir H Kashani, MD, PhD
Ultrawide Field Imaging in Diabetic Retinopathy
8:40AM – 8:50AM
Paolo S Silva, MD
8:40AM – 8:50AM
Paolo S Silva, MD
Imaging Geographic Atrophy: Autofluorescence, OCT, Photos
8:50AM – 9:00AM
Glenn Jaffe, MD
8:50AM – 9:00AM
Glenn Jaffe, MD
Questions and Answers / Discussion
9:00AM – 9:10AM
9:00AM – 9:10AM
Geographic Atrophy and Inherited Retinal Diseases – MODERATOR
9:10AM – 9:40AM
Demetrios Vavvas, MD, PhD
9:10AM – 9:40AM
Demetrios Vavvas, MD, PhD
Geographic Atrophy and Inherited Retinal Diseases – MODERATOR
9:10AM – 9:40AM
Mandeep Singh, MD, PhD
9:10AM – 9:40AM
Mandeep Singh, MD, PhD
Geographic Atrophy and Inherited Retinal Diseases – MODERATOR
9:10AM – 9:40AM
Stephen Tsang, MD, PhD
9:10AM – 9:40AM
Stephen Tsang, MD, PhD
Treating Geographic Atrophy: Balancing Benefits and Risks
9:10AM – 9:20AM
Demetrios Vavvas, MD, PhD
9:10AM – 9:20AM
Demetrios Vavvas, MD, PhD
Clinical Trials for Inherited Retinal Diseases
9:20AM – 9:30AM
Mandeep Singh, MD, PhD
9:20AM – 9:30AM
Mandeep Singh, MD, PhD
Vitamin Supplements for GA or RP: Vitamin A? Not Today
9:30AM – 9:40AM
Jason Comander, MD, PhD
9:30AM – 9:40AM
Jason Comander, MD, PhD
Gene Therapy for Retinal/Choroidal Vascular Diseases
10:10AM – 10:20AM
Peter A Campochiaro, MD
10:10AM – 10:20AM
Peter A Campochiaro, MD
Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR
10:10AM – 11:10AM
Alexander J Brucker, MD
10:10AM – 11:10AM
Alexander J Brucker, MD
Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR
10:10AM – 11:10AM
James Handa, MD
10:10AM – 11:10AM
James Handa, MD
Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR
10:10AM – 11:10AM
Sunir Garg, MD
10:10AM – 11:10AM
Sunir Garg, MD
Macular Edema from RVO: Does It Matter Which Anti-VEGF
10:20AM – 10:30AM
Aleksandra Rachitskaya, MD
10:20AM – 10:30AM
Aleksandra Rachitskaya, MD
Challenges of Sickle Cell Retinopathy
10:30AM – 10:40AM
Jennifer I Lim, MD
10:30AM – 10:40AM
Jennifer I Lim, MD
Treating MacTel: Just Anatomy or Function Too
10:40AM – 10:50AM
Emily Chew, MD
10:40AM – 10:50AM
Emily Chew, MD
ROP and Other Pediatric Retinal Vascular Diseases
10:50AM – 11:00AM
Yoshihiro Yonekawa, MD
10:50AM – 11:00AM
Yoshihiro Yonekawa, MD
Questions and Answers / Discussion
11:00AM – 11:10AM
11:00AM – 11:10AM
Ocular Tumors
11:10AM – 12:00PM
David H Abramson, MD
11:10AM – 12:00PM
David H Abramson, MD
Ocular Tumors – MODERATOR
11:10AM – 12:00PM
Carol L Shields, MD
11:10AM – 12:00PM
Carol L Shields, MD
Ocular Tumors – MODERATOR
11:10AM – 12:00PM
Ivana Kim, MD
11:10AM – 12:00PM
Ivana Kim, MD
Radiation Retinopathy
11:10AM – 11:20AM
Arun D. Singh, MD
11:10AM – 11:20AM
Arun D. Singh, MD
Updates on Retinoblastoma and Histiocytosis
11:20AM – 11:30AM
Jasmine Francis, MD
11:20AM – 11:30AM
Jasmine Francis, MD
Evolving Treatments in Choroidal Melanoma
11:30AM – 11:40AM
Carol L Shields, MD
11:30AM – 11:40AM
Carol L Shields, MD
Oncology Drug Toxicities for the Retina Specialist
11:40AM – 11:50AM
William F Mieler, MD
11:40AM – 11:50AM
William F Mieler, MD
Questions and Answers / Discussion
11:50AM – 12:00PM
11:50AM – 12:00PM
Introduction: International Keynote Talk and 100th Celebration
12:55PM – 1:00PM
J. Fernando Arevalo, MD, PhD
12:55PM – 1:00PM
J. Fernando Arevalo, MD, PhD
Introduction: International Keynote Talk and 100th Celebration
12:55PM – 1:00PM
Neil Bressler, MD
12:55PM – 1:00PM
Neil Bressler, MD
International Keynote Talk: AI Revolution in Retina
1:00PM – 1:10PM
Haotian Lin, MD, PhD
1:00PM – 1:10PM
Haotian Lin, MD, PhD
Choroidal Neovascularization -MODERATOR
1:10PM – 2:00PM
Lucia Sobrin, MD
1:10PM – 2:00PM
Lucia Sobrin, MD
Choroidal Neovascularization -MODERATOR
1:10PM – 2:00PM
Akrit Sodhi, MD, PhD
1:10PM – 2:00PM
Akrit Sodhi, MD, PhD
Choroidal Neovascularization -MODERATOR
1:10PM – 2:00PM
Adam S Wenick, MD, PhD
1:10PM – 2:00PM
Adam S Wenick, MD, PhD
Fixed Dosing, As Needed, or Treat and Extend for CNV
1:10PM – 1:20PM
Akrit Sodhi, MD, PhD
1:10PM – 1:20PM
Akrit Sodhi, MD, PhD
Polypoidal Choroidal Vasculopathy: Special Considerations
1:20PM – 1:30PM
K. Bailey Freund, MD
1:20PM – 1:30PM
K. Bailey Freund, MD
Safety Considerations: Inflammation / Occlusive Vasculitis
1:30PM – 1:40PM
Andre Witkin, MD
1:30PM – 1:40PM
Andre Witkin, MD
Questions and Answers / Discussion
1:40PM – 2:00PM
1:40PM – 2:00PM
Proliferative Diabetic Retinopathy – MODERATOR
2:00PM – 2:30PM
K. Bailey Freund, MD
2:00PM – 2:30PM
K. Bailey Freund, MD
Proliferative Diabetic Retinopathy – MODERATOR
2:00PM – 2:30PM
John Thompson, MD
2:00PM – 2:30PM
John Thompson, MD
Proliferative Diabetic Retinopathy – MODERATOR
2:00PM – 2:30PM
Richard B Rosen, MD
2:00PM – 2:30PM
Richard B Rosen, MD
Proliferative Diabetic Retinopathy: Anti-VEGF, PRP, or Both
2:00PM – 2:10PM
Lee M Jampol, MD
2:00PM – 2:10PM
Lee M Jampol, MD
Evolving Indications for Surgery in Proliferative DR
2:10PM – 2:20PM
Dean Eliott, MD
2:10PM – 2:20PM
Dean Eliott, MD
Questions and Answers / Discussion
2:20PM – 2:30PM
2:20PM – 2:30PM
Current Role of Fluorescein Angiography in DME
3:00PM – 3:10PM
Yannis Mantas Paulus, MD
3:00PM – 3:10PM
Yannis Mantas Paulus, MD
Diabetic Macular Edema – MODERATOR
3:00PM – 4:00PM
Mira Sachdeva, MD, PhD
3:00PM – 4:00PM
Mira Sachdeva, MD, PhD
Diabetic Macular Edema – MODERATOR
3:00PM – 4:00PM
Allen C Ho, MD
3:00PM – 4:00PM
Allen C Ho, MD
Diabetic Macular Edema – MODERATOR
3:00PM – 4:00PM
Ishrat Ahmed, MD, PhD
3:00PM – 4:00PM
Ishrat Ahmed, MD, PhD
New Agents for DME: Just Durable or More Durable
3:10PM – 3:20PM
Judy E Kim, MD
3:10PM – 3:20PM
Judy E Kim, MD
Port Delivery System Updates for DME
3:20PM – 3:30PM
Carl D Regillo, MD
3:20PM – 3:30PM
Carl D Regillo, MD
AI in DME: At Its Infancy or A Flash in the Pan
3:30PM – 3:40PM
T. Y. Alvin Liu, MD
3:30PM – 3:40PM
T. Y. Alvin Liu, MD
Approaches to Prevent Worsening of Diabetic Retinopathy
3:40PM – 3:50PM
Neil Bressler, MD
3:40PM – 3:50PM
Neil Bressler, MD
Questions and Answers / Discussion
3:50PM – 4:00PM
3:50PM – 4:00PM
Big Data and Social Determinants of Health in Retinal Diseases
4:00PM – 4:10PM
Cindy X Cai, MD
4:00PM – 4:10PM
Cindy X Cai, MD
Special Topics in Retina for 2025 – MODERATOR
4:00PM – 5:00PM
Lee M Jampol, MD
4:00PM – 5:00PM
Lee M Jampol, MD
Special Topics in Retina for 2025 – MODERATOR
4:00PM – 5:00PM
Joseph Anaya, MD, MBA
4:00PM – 5:00PM
Joseph Anaya, MD, MBA
Special Topics in Retina for 2025 – MODERATOR
4:00PM – 5:00PM
Jose S Pulido, MD, MPH, Professor
4:00PM – 5:00PM
Jose S Pulido, MD, MPH, Professor
Panel Discussion: Women in Retina in 2025
4:10PM – 4:30PM
Adrienne Scott, MD
4:10PM – 4:30PM
Adrienne Scott, MD
Panel Discussion: Women in Retina in 2025
4:10PM – 4:30PM
Judy E Kim, MD
4:10PM – 4:30PM
Judy E Kim, MD
Panel Discussion: Women in Retina in 2025
4:10PM – 4:30PM
Jasmine Francis, MD
4:10PM – 4:30PM
Jasmine Francis, MD
Panel Discussion: Women in Retina in 2025 – MODERATOR
4:10PM – 4:30PM
Jennifer I Lim, MD
4:10PM – 4:30PM
Jennifer I Lim, MD
New Agents for nAMD: Just Durable or More Durable
4:30PM – 4:40PM
Susan Bressler, MD
4:30PM – 4:40PM
Susan Bressler, MD
Therapies for Central Serous Chorioretinopathy
4:40PM – 4:50PM
Jay Chhablani, MD
4:40PM – 4:50PM
Jay Chhablani, MD
Summary: MACULA 2025 and Plans for MACULA 2026
4:50PM – 5:00PM
J. Fernando Arevalo, MD, PhD
4:50PM – 5:00PM
J. Fernando Arevalo, MD, PhD
Summary: MACULA 2025 and Plans for MACULA 2026
4:50PM – 5:00PM
Neil Bressler, MD
4:50PM – 5:00PM
Neil Bressler, MD
Be the first to review “Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025”
You must be logged in to post a review.
Related products
Reviews
There are no reviews yet.